Search for: "APP Pharmaceuticals, LLC" Results 101 - 120 of 161
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jan 2012, 8:16 am
The Consumer Electronics Association, which is behind the show, has been a vocal opponent of the two bills circulating in Congress that would help Hollywood titans, record labels and pharmaceutical firms enforce copyright infringement laws online. [read post]
12 Jan 2012, 1:15 pm by Bexis
“[W]e are troubled by the lack of uniformity and certainty inherent in the case-by-case approach and fear the resulting disincentive for pharmaceutical manufacturers to develop new products. [read post]
2 Dec 2011, 2:00 pm by Bexis
APP Pharmaceuticals, LLC, 783 F. [read post]
14 Nov 2011, 4:46 pm by FDABlog HPM
Court of Appeals for the Federal Circuit notifying the Court of the enactment of Section 37 and asserting that it resolves the merits of the ongoing ‘404 patent PTE litigation with ANDA sponsor APP Pharmaceuticals, LLC (“APP”). [read post]
20 Oct 2011, 7:55 am by FDABlog HPM
Court of Appeals for the Federal Circuit notifying the Court of the enactment of Section 37 and asserting that it resolves the merits of the ongoing ‘404 patent PTE litigation with APP Pharmaceuticals, LLC (“APP”) (see our previous posts here, here, and here). [read post]
26 Sep 2011, 12:30 pm by FDABlog HPM
Court of Appeals for the Federal Circuit (where APP Pharmaceuticals, LLC (“APP”) has been duking it out with MDCO – see here and here) given all of the twists and turns that have occurred with the ANGIOMAX ‘404 patent PTE over the years. [read post]
1 Sep 2011, 5:10 pm by INFORRM
  As Justice Kennedy puts it: “the State defends the law by insisting that “pharmaceutical marketing has a strong influence on doctors’ prescribing practices. [read post]
18 Aug 2011, 5:00 am by Bexis
TVT Records, LLC, 2007 WL 3232274, at *30 (S.D. [read post]
12 Aug 2011, 10:06 am
The lawsuit arose from an Abbreviated New Drug Application filed with the Food and Drug Administration that had been filed by Teva Parenteral Medicines of Israel, alleging APP Pharmaceuticals LLC of Schaumburg, Illinois, and Barr Laboratories of Montvale, New Jersey. [read post]
11 Aug 2011, 5:25 pm by FDABlog HPM
  Those patents, issued on September 1, 2009 (the ‘727 Patent) and October 6, 2009 (the ‘343 Patent), were timely submitted to FDA for Orange Book listing, and served as flypaper for Paragraph IV patent certifications from several ANDA sponsors, including APP Pharmaceuticals, LLC (“APP”), the company embroiled in a battle with MDCO in the Federal Circuit over a PTE for the ‘404 Patent. [read post]
15 Jul 2011, 1:15 pm
Indianapolis, IN - Patent lawyers for Eli Lilly Company of Indianapolis, Indiana filed a patent infringement judgment suit in the Southern District of Indiana alleging APP Pharmaceuticals LLC of Schaumburg, Illinois infringed patent no.7,772,209 , Antifolate combination therapies, which has been issued by the US Patent Office. [read post]
10 Jul 2011, 11:29 pm by Gordon Johnson
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]